secwatch / observer
8-K filed March 14, 2022, 7:59 PM ET ticker IQV CIK 0001478242
leadership confidence high sentiment neutral materiality 0.50

IQVIA appoints Costa Panagos as President of R&DS, succeeding retiring Richard Staub III

IQVIA HOLDINGS INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Costa Panagos

President of its Research & Development Solutions
IQV · IQVIA HOLDINGS INC.
Effective
2022-04-01
Filed
March 14, 2022, 7:59 PM ET
On March 14, 2022, IQVIA Holdings Inc. (the “Company”) announced the appointment of Costa Panagos as President of its Research & Development Solutions (“R&DS”) business unit, effective April 1, 2022.
Role change

Richard Staub III

President, R&DS
IQV · IQVIA HOLDINGS INC.
Effective
2022-04-01
Successor
Costa Panagos
Filed
March 14, 2022, 7:59 PM ET
Richard Staub III, President, R&DS, will retire from his current role effective April 1, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Costa Panagos was appointed as President of its Research & Development Solutions at IQVIA HOLDINGS INC..

Action
appointed
Role
President of its Research & Development Solutions
Exact text from the filing
On March 14, 2022, IQVIA Holdings Inc. (the “Company”) announced the appointment of Costa Panagos as President of its Research & Development Solutions (“R&DS”) business unit, effective April 1, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Staub III retired as President, R&DS at IQVIA HOLDINGS INC..

Action
retired
Role
President, R&DS
Exact text from the filing
Richard Staub III, President, R&DS, will retire from his current role effective April 1, 2022
View on SEC.gov

IQVIA HOLDINGS INC. filing history →

Source: SEC EDGAR
accession 0001478242-22-000045
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.